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ABSTRACT: Development and optimization of a hydrogel with impregnated silver sulfadiazine was pursued, for antimicrobial topical
applications. The selected hydrogel exhibited a homogeneous appearance, with whitish colloration and devoid of any fractures or cracks.
The content in impregnated silver sulfadiazine was within established limits (1%, w/w) with a standard deviation of up to 1.28%. The
hydrogel presented a good characteristic in relation to release of the active antimicrobial principle, verified through swelling tests and
antimicrobial activity. The swelling tests indicated a higher increase in weight during the first 6 h of contact with a moist environment,
with a maximum value of 266.00 ± 0.81, and with maintenance of the original shape of the hydrogel. The impregnated silver sulfadiazine
presented antimicrobial activity, as expected, indicating a prolonged release of the drug. The infrared spectra of the hydrogel with
impregnated silver sulfadiazine indicated that the drug did not engage in any bonds with the polymeric matrix, which otherwise could
have reduced its antimicrobial activity. The mechanical resistance tests produced good results, indicating that the hydrogels may be utilized
in different locations of the human body with skin lesions. C© 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J
Pharm Sci 104:2241–2254, 2015
Keywords: hydrogels; PVA; silver sulfadiazine; antimicrobial topical applications; physical characterization; polymeric drug delivery
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INTRODUCTION
Among the various dosage forms developed as modified-release
systems, hydrogels can be considered controlled-release sys-
tems for drugs of topical application, depending on both the
type of formulation and application in which they are used.1
Hydrogels are three-dimensional (3D) networks of hydrophilic
polymers that, in contact with water, swell and may release the
drug by different mechanisms.2 In this sense, hydrogels are of
particular interest in the treatment of topical wounds because
of their intrinsic low toxicity, potential for extended release of
drugs, and the ability to keep the wound hydrated.3–5 Review
studies have pointed toward the use of various types of natu-
ral and/or synthetic polymers for the preparation of hydrogels,
such as poly(acrylic acid), poly(ethylene oxide), poly(ethylene
glycol) (PEG), poly(vinyl pyrrolidone), polyvinyl alcohol (PVA),
polyglycerol esters of fatty acids, carbomers, sodium alginate,
chondroitin sulfate, pectin, dextran, carboxymethylcellulose,
and other cellulose derivatives, chitosan, gelatin, and gums.6–11
PVA is extensively used to produce hydrogels aiming at the
treatment of topical ulcers. PVA is a nontoxic, biocompatible
polymer that has excellent film-forming properties and ease of
processability, as well as mechanical, thermal, and chemical
resistances.5,10,12,13 Dextrans are also widely used for biomed-
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ical applications because of their biocompatibility and ease of
modification and biodegradation.14 For the treatment of skin le-
sions, among various substances, there is a consensus in the use
of silver sulfadiazine at 1% (w/w) for the treatment of burns and
skin infections. Silver sulfadiazine is effective against a wide
microbiota of gram-negative bacteria such as Escherichia coli,
Enterobacter, Klebsiella, and Pseudomonas aeruginosa, includ-
ing also gram-positive bacteria such as Staphylococcus aureus
and yeasts such asCandida albicans.15 Silver sulfadiazine is in-
dicated in the treatment and prevention of infections in burns,
with classification of anti-infectant agent in the form of cream
at 1% (w/w); short-term adjuvant treatment, for infections in
both leg ulcers and pressure ulcers; prophylaxis of infection
in areas of skin grafts prone to abrasion.16 Silver sulfadiazine
in the form of cream requires multiple daily applications, in-
terfering with the healing process as the wound dressing ex-
poses patients to infectious agents, in addition to the pain and
trauma that it causes because the cream is not biodegradable
and requires removal before reapplication.17 Considering the
growing importance of the pharmaceutical form hydrogel, the
aim of the present research work was to develop and evaluate a
hydrogel using PVA and/or dextran as raw materials, contain-
ing incorporated silver sulfadiazine, for antimicrobial topical
applications. The optimized hydrogel formulation integrating
silver sulfadiazine was subsequently fully characterized
physicochemically, encompassing determination of pore size
and porosity via X-ray tomography, surface morphology via
scanning electron microscopy (SEM), thermal analyses via
thermogravimetric analysis (TGA), and differential scanning
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calorimetry (DSC), Fourier transform infrared (FTIR) spec-
trophotometry, and X-ray diffraction (XRD) analyses.
MATERIALS AND METHODS
Materials
Chemicals
All reagents used were of analytical grade or better, and were
used without further purification. Tap water was purified in
a Milli-Q Elga Purelab system (Molsheim, France) to a final
conductivity of approximately 18.2 M cm−1. PVA with a hy-
drolysis degree of 89% (PVA89), aqueous glutaraldehyde solu-
tion (25%, v/v), and PEG 4000 were purchased from Dinaˆmica
Produtos Quı´micos Ltda (Diadema, Sa˜o Paulo, Brazil). PVA
with a hydrolysis degree of 98.99% (PVA99) was purchased
from Sigma–Aldrich (St. Louis, Missouri). Dextran from Am-
resco Biochemicals Life Research Products was acquired from
Sellex (Sa˜o Paulo, Brazil). Silver sulfadiazine with a purity de-
gree of 100.06%, considering 29.3% silver, was purchased from
Valdequı´mica Produtos Quı´micos Ltda (Sa˜o Paulo, Brazil). The
ointment with silver sulfadiazine at 1% (w/w), with tradename
Dermazine R© andmanufactured by Silvestre Labs Quı´mica Far-
maceˆutica Ltda (Rio de Janeiro, Brazil) was purchased from
the local market at the city of Sorocaba (Sorocaba, Sa˜o Paulo,
Brazil).
Biological Materials
The bacterial strain utilized in the antimicrobial assays was
Staphylococcus aureus CCCD S007, and was acquired from Ce-
far Diagno´stico Ltda (Sa˜o Paulo, Brazil). The microbiological
growth media utilized were BHI broth (Brain Heart Infusion)
from Fluka Analytical (St. Louis, Missouri) and Manitol Salt
Agar from Prodimol Biotecnologia S.A. (Sa˜o Paulo, Brazil).
Analytical Equipment
Fourier transform infrared spectra were gathered in a FTIR
Spectrophotometer from Agilent (model Cary 630; Santa
Clara, California). X-ray diffractograms were gathered in a
X-ray diffractometer from Shimadzu (model XRD7000; Ky-
oto, Japan). Thermogravimetric characterization of the hydro-
gels was accomplished via thermogravimetric analysis (TGA),
whereas thermal analyses were pursued by DSC. TGA anal-
yses were carried out using a thermogravimeter from TA In-
struments (model 2050; New Castle, Delaware), whereas the
DSC analyses were carried out using a differential scanning
microcalorimeter from TA Instruments (model MDSC 2910).
The surface of the hydrogels containing incorporated silver
sulfadiazine was duly observed in a scanning electron micro-
scope (model JSM-63660 CV; JEOL, Tokyo, Japan). Hydrogel
samples were sputter-coated with colloidal gold under vac-
uum, and placed in the microscope chamber. Microphotographs
were gathered using electron beams with acceleration speeds
of 10–20 keV. The samples were randomly scanned and pho-
tomicrographed at magnifications of ×50, ×200, and ×1000. A
computed tomographer via X-ray transmission fromBrukermi-
croCT (model SkyScan 1174; Kontich, Belgium), and an energy-
dispersion X-ray fluorescence (EDXRF) spectrometer from Shi-
madzu (model EDX-700) were utilized in all nondestructive
analyses, for gathering tomographic images of the hydrogels.
The analysis software utilized for processing the tomographic
images were CTVox
TM (version 2.6.0 r908–64bit, from Bruker
microCT) and CTanTM (version 1.13.5.1–64bit, from Bruker
microCT), and CTvol (version 2.2.3.0–64bit, from Bruker mi-
croCT).
Experimental Procedures
Preparation of Hydrogels
To produce the hydrogels, aqueous dispersions of PVA99 (10%,
w/v), PVA89 (10%, w/v), dextran (15%, w/v), and silver sulfadi-
azine (10%, w/v) were previously prepared. One-hundred gram
PVA (99 or 89) was weighed in an analytical scale, added with
1000 mL ultrapure water and the resulting mixture kept under
magnetic stirring (300 rpm) and heating (80 ± 5°C) dur-
ing approximately 2 h, using a magnetic stirring device from
Fisaton (model 752 A; Sa˜o Paulo, Brazil). Following this time
period, the mixture was stirred during approximately 6 min
at 5200 rpm using an UltraTurrax (model T25D; IKA Werke
GmbH and Company KG, Staufen, Germany) homogenizer. Af-
terwards, the mixture was left under mechanical stirring at
80 ± 5°C for approximately 2 h. The dextran aqueous solu-
tion at 15% (w/v) was prepared by adding 150 g dextran with
1000 mL ultrapure water, with mechanical stirring in a mag-
netic stirring device (300 rpm) at room temperature (±25°C)
during approximately 10 min. The aqueous solution of silver
sulfadizine at 10% (w/v) was prepared by dispersing 10 g of
silver sulfadiazine in 100 mL of PEG 4000 at room temper-
ature (±25°C). Eleven hydrogel formulations and two cross-
linking methodologies were proposed and duly tested, being
one a chemical method (using glutaraldehyde as cross-linking
agent) and the other a physical one (cryogelification). All hy-
drogel formulations tested are described in Table 1. PVA dis-
persions (either PVA99 or PVA89) and dextran were mixed and
heated up to 80 ± 5°C under magnetic stirring (300 rpm) for
Table 1. Formulations Tested for Hydrogels of PVA/Dextran with Silver Sulfadiazine
Hydrogel Formulation
Component (%, w/w) Ia IIa IIIa IV Va VIa VIIa VIIIa IX X XI
PVA99 20 15 10 12.5 15 15 5 – 10 7.5 5
PVA89 – – 10 – 5 5 15 20 – – –
Dextran – 4.5 – 5.25 – 4.5 4.5 – 6.75 8.25 9.75
PEG 4000 10 10 10 10 10 10 10 10 10 10 10
Silver sulfadiazine 1 1 1 1 1 1 1 1 1 1 1
Ultrapure H2O, ast 100 100 100 100 100 100 100 100 100 100 100
aFor the chemical cross-linking process, 5.0 mL of glutaraldehyde aqueous solution at 25% (v/v) were added.
ast, amount sufficient to; PVA99, polyvinyl alcohol with 99% degree of hydrolysis; PVA89, polyvinyl alcohol with 89% degree of hydrolysis.
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approximately 10 min. Subsequently, the silver sulfadiazine
solution at 10% (w/w) was incorporated and the resulting dis-
persion was maintained under magnetic stirring for an extra
30 min (300 rpm). After this time period, the dispersions were
kept at rest until temperature equilibration with room temper-
ature (±25°C). Subsequently, 5.0 mL glutaraldehyde solution
at 25% (v/v) were added, the resulting dispersion duly homoge-
nized, poured into plastic molds, and dried at 60°C in a Fanem
incubator (model 515 A; Karnataka, India). After completion
of the hydrogel’s polymerization process, the hydrogels were
thoroughly washed with phosphate buffer pH 7.0, so as to vir-
tually eliminating all nonreacted (free) glutaraldehyde. The
hydrogel samples were then cut (2.5 × 3.0 cm2) wrapped in
PVC (polyvinyl chloride) film and stored in the dark. For those
hydrogel formulations prepared via criogelification, following
homogenization and rest, they were poured into plastic molds
and kept at −4°C during 14 h and then at 25°C during 2 h,
for five consecutive cycles. The hydrogels were then dried in an
incubator set at 60°C.
Morphological Characteristics
The hydrogel films formed were initially analyzed with respect
to their macroscopic morphological characteristics, considering
the absence of air bubbles, the presence of cracks and homo-
geneity. This evaluation was performed by both naked eye and
magnifying glass. Thickness of the hydrogel films was deter-
mined with the aid of a manual measuring caliper from Mitu-
toyo Sul Americana Ltda (Suzano, Brazil). Each hydrogel film
was measured at 10 different points, and the average thickness
and associated standard deviation were duly calculated.
SEM Analyses
The surface of the hydrogel films containing silver sulfadi-
azine was duly observed in a scanning electron microscope
(from JEOL; model JSM-63660). Hydrogel samples were coated
with colloidal gold under vacuum, and placed in the micro-
scope chamber.Microphotographs were gathered using electron
beams with 10 keV energy.
FTIR Spectrophotometry Analyses
The infrared spectra of samples of silver sulfadiazine, and of
samples of selected hydrogels (viz., formulation III) without
and with incorporated silver sulfadiazine, were gathered using
an FTIR spectrophotometer from Agilent (model Cary 630) in
the wavelength range from 4000 to 400 cm−1, with a resolution
of 4 cm−1 and using Happ-Genzel apodization.
XRD Analyses
X-ray diffractograms of silver sulfadiazine, and of samples of
selected hydrogels (viz., formulation III) without and with in-
corporated silver sulfadiazine, were gathered in a X-rayDiffrac-
tometer from Shimadzu (model XRD7000), using X-ray radi-
ation from a copper lamp with radiation K" (8 = 1.5418 A˚)
filtered through a Cu target. The X-ray scanningwas performed
at diffraction angles of 2-2 (from 5° to 90°, with increments of
0.02° and rate of 2°/min), with a voltage of 40 kV, electric cur-
rent intensity of 30 mA, and X-ray power of 3 kW.
Mechanical Resistance Properties
Mechanical properties of the hydrogels were evaluated using a
texturometer from Stabile Micro Systems (model TA-TX Plus;
Godalming, United Kingdom), evaluating parameters such as
resistance to perforation, relaxation, and resilience. The de-
termination parameters were set as distance of 5 mm for the
perforation resistance tests, distance of 2mm for both resilience
and relaxation tests, and a maximum force of 5 kg for all tests.
All determinations were performed in triplicate.
Thermal Analyses via TGA and DSC
Thermogravimetric characterization of the hydrogel formula-
tions was accomplished via TGA, whereas thermal analyses
were pursued by DSC. The TGA analyses were carried out in
a thermogravimeter from TA Instruments (model 2050), using
alumina pans for containing the hydrogel samples under inert
(argon) atmosphere. For the thermogravimetric analyses, sam-
ples were heated from approximately 20°C up to 500°C, and
data (weight loss) were gathered at a sampling rate of 2.0 s per
data point. For the DSC analyses, one has used a differential
scanning microcalorimeter also from TA Instruments (model
MDSC 2910). For every calorimetric assay, approximately 7 (be-
tween 6.48 and 7.93) mg of hydrogel formulation were weighed
directly into the interior of high-pressure aluminum pans, and
duly sealed by pressure. A reference aluminum pan was also
prepared by simply sealing air inside an empty case. The sam-
ples were then subjected to a linear temperature increase from
approximately 20°C up to 250°C, at a constant heating rate of
10°C/min, under an inert atmosphere maintained with a con-
stant flow of argon of 50 mL/min, during which the amount of
heat absorbed by the hydrogel samples was recorded. During
the analyses, data (heat absorption) were gathered at a sam-
pling rate of 0.2 s per data point.
Swelling Degree
The degree of swelling of the hydrogels was determined accord-
ing to the methodology described by Pal and Pal,18 using the
equation: Swelling degree = [(Mt −M0)/M0
] × 100, where Mt
is the mass of swelled sample at time t, and M0 is the initial
mass of dry sample. All hydrogel samples were put in contact
with 50 mL ultrapure water during 1, 2, 3, 6, 12, 24, and 48 h.
All swelling assays were carried out in triplicate.
Moisture Content Analyses via Infrared Heating
For determination of the moisture content, a moisture ana-
lyzer producing heating via an halogen lamp was used (Shi-
madzu;modelMOC63U), equippedwith a programmable timer,
self-calibration, and temperature adjusting between 50°C and
200°C. The parameters utilized were temperature of 60°C in
“slow” mode.
Silver Content Determination by X-ray Fluorescence Analyses
The silver content of the hydrogels impregnated with silver
sulfadiazine was determined using a EDXRF spectrophotome-
ter from Shimadzu (model EDX-700), which comprised an Rh
tube and a Si(Li) semiconductor detector. Voltage applied to
the X-ray tube was of 50 kV, with 25% lag time in the detector.
The spectra were gathered sequentially, with a resolution of
0.02 keV, from 0 to 40 keV. The irradiation time was set at
120 s.
Tomographic Analyses via X-ray Transmission
The tomographic images were gathered using a third gener-
ation X-ray transmission tomograph.19 The hydrogel samples
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were placed inside the tomograph chamber, and image slices
were gathered using the following configurations of the tomo-
graphic system: operating voltage set at 29 kV and electric cur-
rent with 415 :A. The technique employed for obtaining the
tomographic image involved acquisition of a large number of
radiographs of the object (image slices), obtained by measuring
the intensity of X-rays transmitted through the hydrogel sam-
ple, at different angular positions. The hydrogel samples were
rotated 180°, with angular increments of 1°, producing 180 ra-
diographs (projections) per image, each containing 652 × 652
pixels with a spatial resolution of 15.85 :m. At the outlet of the
X-ray source, one utilized an Al filter with 0.25 mm thickness.
Appropriate mathematical algorithms were then used to re-
construct the 3D tomographic images of the hydrogel samples,
through the appropriate composition of bi-dimensional (2D) im-
ages. The 3D images possessed 652 × 652 × 652 pixels and the
same spatial resolution of the 2D images, and thus the volume
of data generated for each hydrogel sample is isotropic with
relation to the spatial resolution. Having all the projections
(radiographs gathered at each angular position), one utilized
the software NRecon
TM from Bruker microCT (version 1.6.9.4),
which uses the algorithm of Feldkamp et al.20 in the process of
reconstructing the tomographic images.
Evaluation of Antimicrobial Activity of the Hydrogels via the Agar
Diffusion Method
The antimicrobial efficacy of the hydrogels integrating sil-
ver sulfadiazine was determined by applying the agar diffu-
sion technique for susceptibility to antimicrobials described
by Bauer et al.21 and Jorgensen and Ferraro,22 as well as ac-
cording to the standards of the Clinical and Laboratory Stan-
dards Institute.23 The assays were carried out in duplicate
using a strain of Staphylococcus aureus (CCCD S007 – Ce-
far Diagno´stico Ltda, Sa˜o Paulo, Brazil). The Staphylococcus
aureus strain was, initially, inoculated in BHI nutritive broth
(Brain Heart Infusion) and maintained at 37 ± 0.5°C during
24 h, to allow growth of the bacteria. Following this time pe-
riod, the bacterial culture was inoculated by spreading on two
Petri dishes containing mannitol salt agar as culture medium,
and the samples to be tested were then applied on the inocu-
latedmedium, in duplicate, with the aid of sterile tweezers near
a Bunsen burner flame: hydrogel discs with silver sulfadiazine
(7.0 mm in diameter and average weight of 8.00 ± 0.01 mg),
the negative standard of inhibition (hydrogel disc without sil-
ver sulfadiazine, with 7.0 mm in diameter), and the positive
standard of inhibition [10 mg of reference ointment of silver
sulfadiazine at 1% (w/w) (with tradename Dermazine R©)]. The
Petri dishes were then inverted and incubated under aerobic
conditions at 37 ± 0.5°C during 24 h. After this time period,
the plates were visually inspected for observation (or not) of
any growth inhibition halos.
Study of the Kinetics of Drug Release (Bioavailability) from the
Hydrogel
The drug release experiments were carried out by measuring
the potential difference in an aqueous medium where a por-
tion of hydrogel-containing silver sulfadiazine was immersed,
using a combined silver electrode (model 9157; ThermoScien-
tific Orion, San Jose´, California) connected to a millivoltmeter
(model pH300; pH analyzer from Analyser Instrumentac¸a˜o
Analı´tica, Sa˜o Paulo, Brazil). Initially, one tested magnetic
stirring of the aqueous medium with the immersed hydrogel
sample, as measures involving specific electrodes require ho-
mogenization of the reaction medium. However, the magnetic
stirring promoted a complete (and accelerated) dissolution of
the hydrogel. Hence, one opted to integrate a peristaltic pump,
for continuous recirculation of the medium without promoting
turbulent flow conditions. The peristaltic pump used (model
MP13GJ-4; Ismatec, Glattbrugg, Switzerland) was connected
to Tygon tubing (2.54 mm internal diameter). A weight sam-
ple of hydrogel of 0.2030 g [containing 1% (w/w) silver sul-
fadiazine] was immersed in 20 mL ultrapure water at room
temperature (25 ± 0.1°C). Potential difference of the medium
where the hydrogel was immersed was gathered at predeter-
mined intervals of time, using the aforementioned combined sil-
ver electrode connected to a millivoltmeter. All measurements
were gathered in mV by time of immersion of the hydrogel.
The experiments were terminated when a silver sulfadiazine
concentration plateau was reached.
RESULTS AND DISCUSSION
In the hydrogel formulations proposed in the research effort
described herein, combinations of PVA with several degrees of
hydrolysis, dextran, and silver sulfadiazine at 1% (w/w) were
evaluated. The concentration of 1% (w/w) of silver sulfadiazine
was chosen because of both its consensus in the treatment of
burns and to the fact that commercial pharmaceutical formu-
lations present such concentration. PVA and dextran were the
polymers chosen to be utilized in the preparation of suitable
hydrogels, as they present good characteristics for producing
films.24 In a review paper by Baker et al.,25 these researchers
claim that it is possible to produce soft hydrogels with approxi-
mately 10% (w/w) PVA and rigid hydrogels with approximately
50%–60% (w/w) PVA. The major purpose of the research effort
described herein was to produce a hydrogel with malleability,
although with a certain resistance so that it could be utilized
for topical applications. With this in mind, one tested formu-
lations encompassing up to 24.5% (w/w) of polymers. PVA sol-
ubility increases with decreasing degree of hydrolysis. Thus,
by mixing PVA polymers with different degrees of hydrolysis,
it is possible to modulate the properties of both solubility and
swelling of PVA and, consequently, release of the drug.26 The
cross-linking process via cryogellification produced nonuniform
hydrogels with uneven distribution of silver sulfadiazine, and
thus one opted by using the chemical cross-linking process with
glutaraldehyde. The hydrogels were analyzed with respect to
homogeneity, resistance to manipulation, and color homogene-
ity. Formulations I, II, III, V, VI, VII, and VIII (see Table 1),
chemically cross-linked with glutaraldehyde, were selected for
the swelling and mechanical resistance tests.
Swelling Degree
Formulations VII and VIII were totally dissolved before com-
pleting 1 h of testing, and so they were discarded from further
testing, by proving to be nonappropriate for using as wound
bandages. From all the formulations tested (see Table 1), hy-
drogel formulations II, III, and V produced the best results (see
Table 2). From inspection of Table 2, it can be observed that a
maximum swelling occurred during the first hours of contact
with ultrapure water (up to 6 h). After this time period, the
hydrogels began to lose mass, probably because of dissolution
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Table 2. Average Swelling Degrees and Associated Standard
Deviations (n = 3) of Selected Hydrogel Formulations Following
Immersion in Water for 1, 3, 6, 12, 24, and 48 h
Immersion Formulation II Formulation III Formulation V
Time (h) (%¯± F) (%¯± F) (%¯± F)
1 200.40 ± 3.88 190.00 ± 1.56 202.50 ± 5.09
3 210.56 ± 2.42 220.00 ± 0.87 234.20 ± 2.39
6 232.61 ± 0.73 266.00 ± 0.81 225.99 ± 1.85
12 179.42 ± 0.53 197.15 ± 2.20 186.54 ± 2.56
24 128.71 ± 1.29 194.32 ± 3.16 155.52 ± 5.00
48 104.76 ± 2.34 172.03 ± 3.01 128.85 ± 1.28
of the films. Such loss of mass was smaller for the hydrogel pro-
duced according to formulation III, and thus this formulation
was selected for further work.
Mechanical Resistance
To determine the mechanical properties of the selected hydro-
gels, these were evaluated with respect to perforation, relax-
ation, and resilience. Themechanical properties of the hydrogel
films aremainly relatedwith the polymer’s ability to formbonds
in polymer chains, making their separation difficult when sub-
ject to mechanical forces.27 The plasticizer used also has an
influence on these properties.28 The analysis of the results con-
sidered the average thickness (0.50± 0.03mm) and the average
weight (344.18 ± 2.65 mg) of the hydrogels with an area of 25
× 30 mm2. The results produced during evaluation of the me-
chanical resistance of selected hydrogel formulations with and
without silver sulfadiazine, with respect to perforation, relax-
ation, and resilience are displayed in Table 3.
Hydrogel formulations II and V, containing in their compo-
sition a higher amount of PVA99 (15%, w/w, of the formula-
tion), exhibited a higher resistance than the hydrogel produced
according to formulation III, which contained only 10% (w/w)
PVA99 in its composition. The hydrogel produced according to
formulation II, incorporating silver sulfadiazine, exhibited a
lower resistance to perforation than its counterpart without
silver sulfadiazine; however, it presented higher values rela-
tive to resilience and relaxation. Hence, it may be concluded
that the presence of silver sulfadiazine improved its viscoelas-
tic characteristics of deformation andmolecular relaxation. Hy-
drogels produced according to formulations III and V presented
a slight decrease in the mechanical resistance for the parame-
ters analyzed, except for the hydrogel produced according to for-
mulation V with silver sulfadiazine, which presented a better
mechanical resistance in relation to resilience than its counter-
part without silver sulfadiazine. The major goal of the research
work undertaken was to develop a hydrogel suitable for appli-
cation in skin wounds. In our perspective, a hydrogel bandage
applied directly to a skin wound that produces exudate should
not strongly adhere to the wound, because its exchange would
become unnecessary painful to the patient and would not allow
re-epithelialization of the wound. Thus, perforation, relaxation,
and resilience were themechanical resistance parameters eval-
uated, whereas adhesiveness or bioadhesiveness were not at all
considered important in the research work developed. The op-
timized hydrogel is intended to be applied to a skin wound and
maintained in place by a bandage, and not to stick or adhere
to the wounded skin. Our perspective is supported by liter-
ature references.29,30 Hydrogels act as moist wound dressing
materials, and are able to both absorb and retain the wound
exudates as well as any contaminating bodies such as bacteria,
within their network structure. Additionally, hydrogels have
been found to both promote fibroblast proliferation by reduc-
ing fluid loss from the wound surface and protect the wound
from external noxae, sine qua non conditions necessary for a
rapid wound healing.30 Hydrogels also help in maintaining a
suitable microclimate on the wound surface, of utmost impor-
tance for the biosynthetic reactions necessary for cellular ac-
tivities. Proliferation of fibroblasts is necessary for a complete
re-epithelialization of the wound, which starts from its edge. As
hydrogels help to maintain the wound moist, keratinocytes can
thus migrate on its surface.30 Hence, hydrogel-based dressings
are of undeniable value in a wide spectrum of wounds, and have
the potential to be utilized on necrotic, sloughy, granulating,
and epithelializing wounds, and can also be applied in infected
wounds, provided that the patient is being treated with sys-
temic antibiotics and the dressing is changed on a daily basis.
In their work, Rippon et al.29 also describe several wound dress-
ing definitions, to include (1) adherent dressings (dressings that
are likely to adhere to any type of drying wound, viz., cotton
gauze and/or simple dressing pads), (2) low-adherent dressings
(dressings with a wound contact surface that is designed to
reduce adherence, viz., absorbent wound dressings), (3) nonad-
herent dressings (dressings thatmaintain amoist gel layer over
the wound that is not expected to adhere, provided that it is not
allowed to dry out, viz., alginates/hydrocolloids and/or hydro-
gels/hydrofibres), and (4) atraumatic dressings (dressings that
do not cause trauma either to the wound or the peri-wound
skin upon removal, viz., soft silicone dressings). Clearly, the
hydrogels developed, optimized, and fully characterized in the
research word described herein, fall in category (3) of the afore-
mentioned descriptions.
Table 3. Results from the Mechanical Resistance Tests (kg ± F) Performed to Selected Hydrogels, Relative to Perforation, Relaxation, and
Resilience (s ± F), as a Function of Applied Force (kg) (AUC)
Perforation Relaxation Resilience
Hydrogel Formulation Force (kg) AUC (kg/s) Force (kg) AUC (kg/s) Force (kg) AUC (kg/s)
II 2.571 ± 0.320 7.445 ± 1.433 0.439 ± 0.072 0.630 ± 0.095 0.352 ± 0.082 0.498 ± 0.135
II w/SDZ 0.781 ± 0.165 3.351 ± 0.225 0.690 ± 0.032 2.974 ± 0.790 0.136 ± 0.037 1.880 ± 0.020
III 0.791 ± 0.162 0.944 ± 0.269 0.258 ± 0.027 0.355 ± 0.039 0.335 ± 0.020 0.439 ± 0.335
III w/SDZ 0.765 ± 0.234 0.915 ± 0.279 0.215 ± 0.043 0.303 ± 0.104 0.193 ± 0.005 0.514 ± 0.032
V 1.373 ± 0.063 2.224 ± 0.190 0.224 ± 0.027 0.298 ± 0.056 0.252 ± 0.017 0.535 ± 0.042
V w/SDZ 0.862 ± 0.181 3.134 ± 0.077 0.456 ± 0.054 0.580 ± 0.032 0.688 ± 0.076 1.926 ± 0.040
n = 3.
AUC, area under the curve; SDZ, silver sulfadiazine.
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Wound dressings containing silver may be utilized in acute
wounds, such as those produced by burns or surgery and in
chronic wounds with infections. The major functions of antimi-
crobial dressings, such as those containing silver, involve re-
ducing the microbial load in acute or chronic wounds, or act as
an antimicrobial barrier for wounds with high risk of infection
or reinfection.31 Additionally, dressings allow the creation of
a moist and warm environment surrounding the wound, thus
bringing benefits to the healing process.32 The developed prod-
uct presents low adhesion to the injured tissue, which is a
desirable feature, as adherent dressings may cause pain and
even more tissue damage during removal.32 However, their fix-
ing requires the use of natural or synthetic bandages (cotton
wool, lint, and gauzes). Because of the product characteristics,
this will virtually not harm the performance of the hydrogel.
Hence, hydrogel adhesion to bandage materials will not be a
problem. The developed hydrogels possess PVC in their compo-
sition, which is a hydrophobic polymer with a low-surface free
energy33 that do not favor attraction of the water molecules
present in the dispersion containing the polymers. As a conse-
quence, this promotes the nonadherence of the hydrogel to the
bandages and healings that may be utilized.
Structural Microanalysis of Selected Hydrogels Incorporating
Silver Sulfadiazine via SEM
From the results gathered in the SEM analyses performed to
the selected hydrogel formulation, namely, formulation III, a
uniform morphology could be observed, with points of depo-
sition of silver sulfadiazine clearly seen in the micrographs
(see Fig. 1) at several magnifications. The polymeric structures
displayed by the hydrogel formulation facilitate solvation and
dissolution upon contact with the solvent, skin moisture, and
with the skin burn, thus being able to slowly release its sil-
ver sulfadiazine content. The hydrogel micrographs in Figure 1
were obtained via the EBSD (electron backscatter diffraction)
technique, which allows the crystallographic analysis of the
material, and it can be observed that the hydrogel topography
is highly uniform.
FTIR Analyses
Fourier transform infrared spectrophotometric analyses allow
identification of functional groups. Each functional group in
particular absorbs radiation in a characteristic frequency of the
infrared spectrum. Thus, a plot of intensity versus radiation fre-
quency, known as infrared spectrum, allows characterization of
the functional groups in a given material,35 which makes FTIR
spectrophotometry quite used in the analysis of the structure
of polymeric systems. This analytical technique may allow clar-
ification of possible interactions between the incorporated drug
and the polymeric matrix of the hydrogel, through the analysis
of the functional groups of the agents involved in the process.
The infrared spectrum of pure silver sulfadiazine (1) and the
infrared spectra of the hydrogels produced according to formu-
lation III, without (2) and with (3) silver sulfadiazine, as well
as, are displayed in Figure 2. Comparing the spectrum of sil-
ver sulfadiazine (see Fig. 2a) with the spectrum of the hydrogel
produced according to formulation III with incorporated silver
sulfadiazine (see Fig. 2c), it can be observed that the charac-
teristic peaks of silver sulfadiazine in the region from 1300 to
1100 cm−1 are present in the hydrogel containing silver sulfa-
diazine (see Fig. 2c) but with reduction in peak intensity. This
Figure 1. Scanning electron micrograph of a hydrogel of PVA with
incorporated silver sulfadiazine (formulation III), gathered using the
electron back-scattered diffraction technique, at different magnifica-
tions: (a) 50×; (b) 200×; (c) 1000×.
clearly suggests that the chemical aspect of the drug was pre-
served during production of the hydrogel, allowing to conclude
that silver sulfadiazine did not engage in any chemical inter-
action with the hydrogel components, only being carried by the
hydrogel, which otherwise could have reduced its antimicrobial
activity.
XRD Analyses
According to Costa Jr. and Mansur,34 the XRD analysis of a
blend of PVA/chitosan revealed that PVA presents an amor-
phous form. The results obtained from the XRD analyses per-
formed to selected hydrogels are displayed in Figure 3 in the
form of normalized diffractograms, for the selected hydrogel
prepared according to formulation III with (see Fig. 3b) and
without (see Fig. 3c) silver sulfadiazine, and allows to observe
an amorphous behavior without peaks of crystallinity. The
small peaks at 22 41° are related with the presence of resid-
ual water in the samples. These results corroborate the results
obtained via SEM, which indicated the formation of an amor-
phous film. The decisive advantage of the methods of analysis
by XRD over other analytical techniques is based on the unique-
ness of the diffraction patterns of crystalline substances, on the
ability to distinguish between elements and their oxides, and on
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Figure 2. Fourier transform infrared spectra of silver sulfadiazine (a), hydrogel produced according to formulation III without silver sulfadiazine
(b), and hydrogel produced according to formulation III with silver sulfadiazine (c). The FTIR spectra were gathered in the region of wavelengths
from 4000 to 400 cm−1 with resolution of 2 cm−1, in an FTIR spectrophotometer from Agilent (model Cary 630).
the possibility of identifying chemical compounds, polymorphic
forms, and mixed crystals, via nondestructive analyses.
Peaks having high intensity and narrow base width are re-
lated to crystalline materials, whereas wide base peaks are re-
lated to amorphous materials. As the intensity of peaks in the
XRD patterns also depends on the concentration of the active
drug, an increase in both the intensity of peaks and diffraction
pattern was expected for the hydrogel impregnated with sil-
ver sulfadiazine (see Fig. 3b) relative to its plain counterpart
(without silver sulfadiazine, see Fig. 3c). Both diffractograms
present the same intensity pattern, but with different ampli-
tudes in several peaks. Normalization of intensity in all diffrac-
tograms was performed by dividing the intensity values by the
maximum intensity value in each diffractogram, thus allowing
a better comparison between the X-ray diffractograms of the
two hydrogels.
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Figure 3. X-ray diffractograms of samples of silver sulfadiazine (a) and of samples of hydrogel prepared according to formulation III with silver
sulfadiazine (b), and of hydrogel prepared according to formulation III without silver sulfadiazine (c). The X-ray diffractograms were gathered
using Cu target-filtered X-rays. The analyses were carried out at diffraction angles of 2-2 (from 5° to 90°, with increments of 0.02° and rate
of 2°/min−1) with voltage of 40 kV, current intensity of 30 mA, and X-ray power of 3 kW, in an X-ray diffractometer from Shimadzu (model
XRD7000).
X-ray Transmission Tomography
From the tomographic analyses via X-ray transmission per-
formed to the hydrogel prepared according to formulation III
with impregnated silver sulfadiazine (see Fig. 4), it can be ob-
served that silver sulfadiazine migrate to the surface of the
hydrogel (purple-bluish layer; see Figs. 4a and 4b) during the
polymerization process. Because of absorbing more radiation
and of its higher atomic density, silver is thus in greater evi-
dence as highlighted in the tomographic images displayed as
Figure 4. These results are in close agreement with those ob-
tained by infrared spectrophotometry that indicated that silver
sulfadiazine probably did not engage in any chemical bonding
with the polymericmatrix. This is clearly an important and pos-
itive data, as by not engaging in any chemical bonding with the
polymeric surface, silver sulfadiazine becomes readily available
and maintains its antimicrobial activity.
Additionally, as can be seen from inspection of the data in
Table 4, the layer of silver sulfadiazine (in purple-bluish in
Fig. 4) is significantly less porous than the polymeric matrix
itself (in green in Fig. 4), and presented a volume 1.5 times
smaller than that of the polymeric film. Anisotropy is the prop-
erty of being directionally dependent, as opposed to isotropy,
which implies identical properties in all directions. Anisotropy
can thus be defined as a difference, when measured along
different axes, in a material’s physical or mechanical prop-
erties (e.g., absorbance). The degree of anisotropy, calculated
as Degree of anisotropy =
[
1−
(
min Eigenvalue
max Eigenvalue
)]
, is 0 for total
isotropy and 1 for total anisotropy. Hence, as can be seen from
inspection of the data in Table 4, the degree of anisotropy is
0.562 and 0.623 for the layer of silver sulfadiazine (in purple-
bluish in Fig. 4) and the polymericmatrix (in green in Fig. 4), re-
spectively, values that are half-way in the aforementioned scale.
When analyzing the structure of these two interconnecting re-
gions, one finds that the layer of silver sulfadiazine has a lower
number of closed pores (viz., 215) than that of the polymeric
matrix (viz., 356), corresponding to an open porosity of 18.54%
Figure 4. Images obtained by tomographic analyses via X-ray trans-
mission of the hydrogel prepared according to formulation III, with
impregnated silver sulfadiazine, being (a) a cross-cut profile image of
the hydrogel with silver sulfadiazine, and (b) slant profile image of the
hydrogel with impregnated silver sulfadiazine. Three-dimensional im-
age slices were gathered using an operating voltage set at 29 kV and
electric current with 415 :A.
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Table 4. Results Obtained from the Tomographic Analyses via X-ray Transmission Performed to the Hydrogel Prepared According to
Formulation III with Impregnated Silver Sulfadiazine
Porosity
Silver Sulfadiazine Layer Polymeric Matrix Without
Parameter (Purple-Bluish Layer in Fig. 4) Silver Sulfadiazine (Green Part in Fig. 4)
Number of layers 79 79
Pixel size 15.85012 :m 15.85012 :m
Total VOI (volume of interest), TV 0.59154 mm3 0.87446 mm3
Object volume, Obj.V 0.48085 mm3 0.58278 mm3
Percent object volume, Obj.V/TV 81.28675% 66.64513%
Total VOI surface, TS 15.15924 mm2 22.44291 mm2
Object surface, Obj.S 24.91102 mm2 52.14039 mm2
Intersection surface, i.S 8.23326 mm2 9.31923 mm2
Object surface–volume ratio, Obj.S–Obj.V 51.80672 mm−1 89.46802 mm−1
Object surface density, Obj.S/TV 42.11200 mm−1 59.62608 mm−1
Fragmentation index, Fr.I −22.89647 mm−1 −52.01265 mm−1
Degree of anisotropy, DA 2.28535 (0.56243) 2.65099 (0.62278)
Eigenvalue 1 0.00787 0.02925
Eigenvalue 2 0.01093 0.06543
Eigenvalue 3 0.01800 0.07754
Number of closed pores, Po.N(cl) 215 356
Volume of closed pores, Po.V(cl) 0.00100 mm3 0.00176 mm3
Surface of closed pores, Po.S(cl) 0.34265 mm2 0.60716 mm2
Closed porosity (percent), Po(cl) 0.20785% 0.30037%
Volume of open pore space, Po.V(op) 0.10970 mm3 0.28992 mm3
Open porosity (percent), Po(op) 18.54394% 33.15408%
Total volume of pore space, Po.V(tot) 0.11070 mm3 0.29167 mm3
Total porosity (percent), Po(tot) 18.71325% 33.35487%
Euler number, Eu.N −1284 −5615
Connectivity, Conn 1694 6435
Connectivity density, Conn.Dn 2863.70196 mm−3 7358.85996 mm−3
and a total porosity of 18.71% for the silver sulfadiazine layer
and an open porosity of 33.15% and a total porosity of 33.35%
for the polymeric matrix. Additionally, the fragmentation in-
dex (see Table 4) gives an index of connectivity and calculates
an index of relative convexity or concavity of the total object
surface, on the principle that concavity indicates connectivity
(and the presence of “nodes”), and convexity indicates isolated
disconnected structures (struts). Lower fragmentation indexes
signify better connected lattices, whereas higher fragmentation
indexes mean a more disconnected structure. The prevalence of
enclosed cavities and concave surfaces can push the fragmen-
tation index to negative values, which was in fact determined
in the analyses performed (see Table 4). These results are quite
important because of the fact that silver sulfadiazine migrates
to one of the surfaces of the polymeric structure during the
polymerization process; the hydrogel can be applied in two dif-
ferent ways, namely, with silver sulfadiazine layer toward the
skin or with the silver sulfadiazine layer opposite from the skin.
If the hydrogel is applied with the silver sulfadiazine toward
the skin, a lower total porosity will make the active princi-
ple readily available to the skin lesion. On the contrary, if the
hydrogel is applied with the silver sulfadiazine layer opposite
from the skin, a higher porosity is important to allow swelling
of the polymeric matrix and concomitant (slow) release of the
active principle to the skin lesion.
Moisture Content
Selected hydrogels without inclusion of the active principle (sil-
ver sulfadiazine) presented a moisture content between 11.35%
Table 5. Results from Moisture Content (%, Average and Associated
Standard Deviation) Determinations of Selected Hydrogel Samples (n
= 3) Using a Moisture Infrared Analyzer
Hydrogel Formulation Moisture Content (%¯ ± F)
II 12.53 ± 0.15
II w/SDZ 10.74 ± 0.08
III 11.47 ± 0.17
III w/SDZ 10.59 ± 0.06
V 11.35 ± 0.10
V w/SDZ 10.93 ± 0.06
(w/w) and 12.53% (w/w), whereas the same hydrogels impreg-
nated with silver sulfadiazine presented a moisture content
between 10.74% (w/w) and 10.93% (w/w) (see Table 5). These
results may be an indication that the drying process utilized
allowed elimination of almost all the free water except, proba-
bly, for that water bound to the polymeric matrix. Considering
the low moisture contents determined, the hydrogel developed
shows a promising characteristic for storage.
In a recent work by Vila et al.,36 a hydrogel of PVA was
developed, integrating nitrofurazone, with a moisture content
of approximately 18% (w/w). In another (recent) work by Vila
et al.,37 a fast dissolution film for buccal applications, made of
the polymer pullulan, presented a moisture content of approx-
imately 14% (w/w). In the present research work, the mois-
ture contents of the hydrogels produced were lower (between
11.35%, w/w, and 12.53%, w/w), indicating that the drying
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Table 6. Average Values and Associated Standard Deviations (n = 3)
of the Silver Contents (ppm) in Selected Hydrogels Obtained by
Energy-Dispersion X-ray Fluorescence Analyses (n = 3)
Hydrogel Silver Silver Silver Sulfadiazine
Formulation Content (ppm) Content (%) Content (%) in the Hydrogel
II 301.00 ± 10.00 0.03010 1.030
III 325.50 ± 15.00 0.03255 1.085
V 384.50 ± 94.00 0.03845 1.280
process utilized was efficient to remove the water, producing
dried hydrogels that can be stored for long periods of time be-
cause of their relatively low-moisture content.
Silver Content Determination by X-ray Fluorescence Analyses
Table 6 displays the results (average and standard deviation)
of silver content in selected hydrogels, obtained by EDXRF.
All analyses were carried out in triplicate. The hydrogels were
prepared so as to present 1% (w/w) silver sulfadiazine. The
molecular weight of silver sulfadiazine is 358.4 g/mol, whereas
that of silver is 107.86 g/mol. Thus, in a molecule of silver
sulfadiazine, 30% of the weight corresponds to silver. When
preparing 100 mL of hydrogel formulation, one utilized 0.1 g
of silver sulfadiazine (1%, w/w). Hence, in 0.1 g silver sulfa-
diazine, there is 0.030% silver. From the results obtained by
EDXRF analyses, hydrogels prepared according to formula-
tions II and III presented a silver sulfadiazine content within
the expected value (1.030% and 1.085%, respectively). For the
hydrogel prepared according to formulation V, the silver sulfa-
diazine content determined was slightly higher than expected
(1.280%, w/w), probably because of an uneven distribution of
silver sulfadiazine in the hydrogel.
Antimicrobial Activity of the Hydrogel
The hydrogel prepared according to formulation III, without
the active principle (functioning as negative standard of inhi-
bition), did not inhibit bacterial growth (no growth inhibition
halo produced). The hydrogel film containing silver sulfadiazine
(8 mg of hydrogel film, containing 0.08 mg silver sulfadi-
azine) promoted amicrobial growth inhibition halo (diameter of
1.45 cm) slightly higher (1.54×) than that of the positive
standard of inhibition (silver sulfadiazine ointment at 1%, w/w,
namely, 10 mg Dermazine R© containing 0.10 mg silver sulfa-
diazine, halo diameter of 0.94 cm), meaning that the hydrogel
containing impregnated silver sulfadiazine allowed a contin-
uous release of the antimicrobial principle, in concentrations
able to inhibit bacterial growth.
Thermal Analyses via TGA and DSC
In general, thermal analyses are useful tools in developing for-
mulations as they allow to evaluate the compatibility between
components of a formulation and the stability and thermal de-
composition of drugs. The data obtained by thermal analysis are
directly related to the final quality of a pharmaceutical product,
allowing to infer aspects of therapeutic efficacy of the product
or the stability of the product throughout the shelf life (or va-
lidity) period. TGA accompany the variation in sample mass
as a function of a linear increase in temperature during a pre-
determined time interval, allowing to determine the thermal
profile of the hydrogels prepared. The TGA curves and the first
derivatives of the mass loss curves for the hydrogels prepared
according to formulation III are displayed in Figure 5, respec-
tively, for the hydrogel without impregnated silver sulfadiazine
(orange curves) and for the hydrogel with impregnated silver
sulfadiazine (blue curves). As can be observed from inspection
of the curves in Figure 5, the thermal behavior is quite similar
in both hydrogels, with a small mass loss around approximately
100°C indicating loss of water. Around 250°C, one can notice a
significant loss of mass, indicating degradation of the compo-
nents in the hydrogels. The first derivative of the weight loss
curve (i.e., the rate of mass change; see Fig. 5) can be used to
tell the points at which weight loss is most apparent (inflection
points), namely, 60°C and 310°C for the hydrogel without silver
sulfadiazine, and 65°C and 290°C for the hydrogel impregnated
with silver sulfadiazine.
Thermal analysis by DSC is an analysis technique in which
the temperature of a sample, compared with the tempera-
ture of a thermally inert material, is recorded as the sample
is heated or cooled at a constant rate.35 The DSC technique
of analysis thus measures the enthalpy of the samples, and
may indicate the glass transition temperature and endother-
mic and/or exothermic events in the samples under scrutiny.
The results of thermal analysis by DSC can be found in
Figure 6. The hydrogel produced according to formulation III
possesses in its composition 10% (w/w) PVA with a degree of
hydrolysis of 89% and 10% (w/w) PVA with a degree of hydroly-
sis of 99%. The thermogram obtained (see Fig. 6) presented two
endothermic events, one at 128.13°C (hydrogel without silver
sulfadiazine) and one at 128.66°C (hydrogel with silver sulfa-
diazine). The other endothermic events occurred at 218.13°C
(hydrogel without silver sulfadiazine) and 215.67°C (hydrogel
with silver sulfadiazine). The data obtained indicated that the
components utilized, in general, only slightly influenced the
thermal behavior of the hydrogels, and also that incorporation
of silver sulfadiazine did not compromise the stability of the
hydrogel for the intended use. The presence of silver sulfadi-
azine promoted a slight shift of the endothermic event close
at 200°C, from 218.13°C to 215.67°C, leading to a better ther-
mal stability of the hydrogel produced according to formula-
tion III. Differential scanning calorimetric analyses of hydro-
gel formulations provided an insight into the state and degree
of crystallinity, and the melting and crystallization behavior of
crystalline materials. The addition (impregnation) of silver sul-
fadiazine promoted a slight increase in the melting temper-
ature peak [absorption peak at 128.13°C and heat absorbed
(melting enthalpy) of 340.6 J/g for the control hydrogel (de-
void of any active drug) formulation, to absorption peak at
128.66°C and heat absorbed (melting enthalpy) of 478.2 J/g
for the optimized hydrogel with impregnated silver sulfadi-
azine (see Fig. 6)], and slight decrease in the decomposition
temperature peak [absorption peak at 218.13°C and heat ab-
sorbed (melting enthalpy) of 10.89 J/g for the control hydrogel
(devoid of any active drug) formulation, to absorption peak at
215.67°C and heat absorbed (melting enthalpy) of 5.018 J/g
for the optimized hydrogel with impregnated silver sulfadiazine
(see Fig. 6)], denoting a narrowing of the melting temperature
range in the case of the optimized hydrogel formulation.
Inclusion of silver sulfadiazine in the hydrogel led to a slight
decrease in the peak of heat absorption (215.67°C), when com-
pared with its blank counterpart (218.13°C), because of amor-
phization of the system. The results obtained from the DSC
thermal analyses carried out with both silver sulfadiazine-
loaded and sulfadiazine-unloaded hydrogel (see Fig. 6) are in
Jodar et al., JOURNAL OF PHARMACEUTICAL SCIENCES 104:2241–2254, 2015 DOI 10.1002/jps.24475
RESEARCH ARTICLE – Pharmaceutics, Drug Delivery and Pharmaceutical Technology 2251
Figure 5. Thermogravimetric curves (a) and first derivative of theweight loss curves (b) of samples of hydrogel prepared according to formulation
III with impregnated silver sulfadiazine (blue lines) and plain hydrogel without silver sulfadiazine (orange lines). The analyses were carried
out in a thermogravimeter from TA Instruments (model 2050), using alumina pans for containing the hydrogel samples under inert (argon)
atmosphere.
close agreement with those obtained from XRD studies (see
Fig. 3); as can be seen from inspection of the DSC thermograms,
impregnation of the hydrogel with silver sulfadiazine led to a
decreased crystallinity with narrowing of the melting profile.
Remarkably, the thermal events depicted in Figure 6 and the
X-ray diffractograms depicted in Figure 3 denote a clear tran-
sition from a crystalline state of the blank hydrogel (see Fig. 6,
orange curve) to an amorphous counterpart (see Fig. 6, hydro-
gel with impregnated silver sulfadiazine, blue curve), thereby
leading to the increased stability observed for the optimized
antimicrobial hydrogel produced.
Mathematical Modeling of Drug Release from Hydrogel
To shed light on the release profile of silver sulfadiazine (sil-
ver sulfadiazine) from the hydrogel, and because after the 2-h
timeframe of assays the amount of silver sulfadiazine released
reached a plateau, one decided to apply the mathematical mod-
els of first-order (ln Qt = ln Q0 + k1 × t, where Qt is the amount
of drug released at time t, Q0 is the initial amount of drug in
dosage form, k1 is a release rate constant, and t is time), Higuchi
(Qt = kH
√
t, where Qt is the amount of drug released at time
t, kH is the Higuchi constant, and t is time), and Korsmeyer–
Peppas (Qt/Q∞ = kKPtn, whereQt is the amount of drug released
at time t, Q is the total amount of drug dissolved when the
dosage form (hydrogel) is exhausted, kKP is the Korsmeyer–
Peppas kinetic constant, n is the diffusion or release exponent,
and t is time) to the drug release data, and in fact silver sul-
fadiazine release from the hydrogel did not occur by diffusion
but by erosion of the polymeric matrix instead. This is in fact
supported by the model fittings performed to the experimental
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Figure 6. Differential scanning calorimetry thermograms of samples of hydrogel prepared according to formulation III with impregnated silver
sulfadiazine (blue lines) and plain hydrogel without silver sulfadiazine (orange lines). The analyses were carried out in a differential scanning
microcalorimeter from TA Instruments (model MDSC 2910), using high-pressure aluminum pans duly sealed by pressure.
Figure 7. Normalized silver sulfadiazine concentration released from hydrogel into the aqueous medium, as function of immersion time. The
inserted plot represents the linear fitting performed to transformed experimental data, using linearized Korsmeyer–Peppas model.
silver sulfadiazine release data, which produced a correla-
tion coefficient r2 = 0.77257 for the first-order model, r2 =
0.87105 for the Higuchi model and a correlation coefficient r2
= 0.96723 for the Korsmeyer–Peppas model. The fittings per-
formed clearly show a poor r2 for both first-order and Higuchi
models and an almost perfect r2 for the Korsmeyer–Peppas
model. Additionally, the diffusion or release exponent (n) in
the Korsmeyer–Peppas model produced by fitting the model
to the silver sulfadiazine release data was n = 0.9321 (in
the Korsmeyer–Peppas drug release model, n = 0.45 suggests
Fickian diffusion, n < 0.89 suggests anomalous diffusion or
non-Fickian diffusion, and n  0.89 suggests erosion of the
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polymeric chain), which clearly suggests that silver sulfadi-
azine release occurred by erosion of the hydrogel’s polymeric
chain. The release results (in the form of normalized silver sul-
fadiazine concentration in aqueous medium, see Fig. 7) have
thus indicated a continuous liberation within the timeframe
assayed, up to 100 min of immersion of the hydrogel in a low-
volume aqueous medium, time after which the silver sulfadi-
azine concentrationmaintained a plateau, thus confirming that
a complete erosion of the polymeric matrix did occur. Although
a slower liberation is intended for real skin wound applications,
one should bear in mind that the experimental setup utilized
involved a complete immersion of the hydrogel under static
flow conditions. In a real situation where the hydrogel is in-
tended for application in a skin wound, the exudation produced
should not be as abundant, and thus erosion of the hydrogel
with concomitant release of silver sulfadiazine should be much
slower.
CONCLUSIONS
In the research effort just described, development and optimiza-
tion of a hydrogel with impregnated SSDZ aiming at antimi-
crobial topical applications was pursued. The developed hydro-
gel displayed a good characteristic in relation to release of the
active antimicrobial principle, verified through swelling tests,
kinetics of release, and antimicrobial activity, and because re-
lease of silver sulfadiazine occurred by erosion of the hydrogel’s
polymeric chain, it can be utilized in occlusive wound dressings
for long periods of time. The hydrogel developed can be consid-
ered as a nonadherent dressing, able to maintain a moist gel
layer over the wound that is not expected to adhere, neither to
the wound or the bandage, provided that it is not allowed to dry
out.
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